Enhanced expression of ERα in astrocytes modifies the response of cortical neurons to β-amyloid toxicity

Neurobiology of Disease

Volumn 33, Issue 3, 2009, Pages 415-421

  Carbonaro, Viviana ^a   Caraci, Filippo ^a   Giuffrida, Maria Laura ^a   Merlo, Sara ^a,b   Canonico, Pier Luigi ^b   Drago, Filippo ^a   Copani, Agata ^a   Sortino, Maria Angela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

amyloid; Alzheimer's disease; Cortical neurons; Estrogen; Neuroprotection; Reactive glia

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; SMALL INTERFERING RNA; DRUG DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BRAIN; CELL CULTURE; CELL SURVIVAL; CULTURE MEDIUM; DRUG EFFECT; GENE SILENCING; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BRAIN; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE KNOCKDOWN TECHNIQUES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 60849106321     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.11.017     Document Type: Article

References (46)

1. Bishop J., and Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell. Neurosci. 5 (1994) 303-308
2. Blurton-Jones M., and Tuszynski M.H. Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol. 433 (2001) 115-123
3. Boche D., Cunningham C., Gauldie J., and Perry V.H. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J. Cereb. Blood Flow Metab. 23 (2003) 1174-1182
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., and Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 18 (1998) 9594-9600
6. Chae H.S., Bach J.H., Lee M.W., Kim H.S., Kim Y.S., Kim K.Y., Choo K.Y., Choi S.H., Park C.H., Lee S.H., Suh Y.H., Kim S.S., and Lee W.B. Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in PC12 through a receptor-dependent pathway. J. Neurosci. Res. 65 (2001) 403-407
7. Chen S., Nilsen J., and Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective out come in hippocampal neurons: therapeutic implications. Endocrinology 147 (2006) 5303-5313
8. Cheskis B.J., Greger J.G., Nagpal S., and Freedman L.P. Signaling by estrogens. J. Cell Physiol. 213 (2007) 610-617
9. Copani A., Condorelli F., Caruso A., Vancheri C., Sala A., Giuffrida Stella A.M., Canonico P.L., Nicoletti F., and Sortino M.A. Mitotic signaling by β-amyloid causes neuronal death. FASEB J. 13 (1999) 2225-2234
10. Cordey M., and Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res. 1045 (2005) 217-223
11. Dhandapani K.M., and Brann D.W. Estrogen-astrocyte interactions: implications for neuroprotection. BMC Neurosci. 7 (2002) 3-6
12. Dhandapani K.M., and Brann D.W. Neuroprotective effects of estrogen and tamoxifen in vitro a facilitative role for glia?. Endocrine 21 (2003) 59-66
13. Dhandapani K.M., Wade F.M., Mahesh V.B., and Brann D.W. Astrocytes-derived transforming growth factor-beta mediates the neuroprotective effects of 17-beta-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146 (2005) 2749-2759
14. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., and Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol mediated protection against brain injury. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1952-1957
15. Gamerdinger M., Manthey D., and Behl C. Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells-implications for neuroprotection against Ca-mediated excitotoxicity. J. Neurochem. 97 (2006) 57-68
16. Garcia-Ovejero D., Veiga S., Garcia-Segura L.M., and DonCarlos L.L. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol. 450 (2002) 256-271
17. Gibbs R.B., Wu D., Hersh L.B., and Pfaff D.W. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trk A, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129 (1994) 70-80
18. Gollapudi L., and Oblinger M.M. Stable transfection of PC12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation. J. Neurosci. Res. 56 (1999) 99-108
19. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
20. Greenfield J.P. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vescicle biogenesis. J. Biol. Chem. 277 (2002) 12128-12136
21. Honda K., Shimohama S., Sawada H., Kihara T., Nakamizo T., Shibasaki H., and Akaike A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J. Neurosci. Res. 64 (2001) 466-475
22. Hsieh Y.C., Yu H.P., Frink M., Suzuki T., Choudhry M.A., Schwacha M.G., and Chaudry I.H. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage. Am. J. Pathol. 170 (2007) 1210-1218
23. Ishunina T.A., and Swaab D.F. Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer's disease. Neurob. Aging 22 (2001) 417-426
24. Ishunina T.A., and Swaab D.F. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Exp. Neurol. 183 (2003) 159-172
25. Kumar D.M., Perez E., Cai Z.Y., Aoun P., Brun-Zinkernagel A.M., Covey D.F., Simpkins J.W., and Agarwal N. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radic. Biol. Med. 38 (2005) 1152-1163
26. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., and Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
27. Lu Y.P., Zeng M., Hu X.Y., Xu H., Swaab D.F., Ravid R., and Zhou J.N. Estrogen receptor alpha immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. Exp. Neurol. 183 (2003) 482-488
28. Marin R., Guerra B., Hernandez-Jimenez J.G., Kang X.L., Fraser J.D., Lopez F.J., and Alonso R. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscence 121 (2003) 917-926
29. Miller R.H., Abney E.R., David S., Ffrench-Constant C., Lindsay R., Patel R., Stone J., and Raff M.C. Is reactive gliosis a property of a distinct subpopulation of astrocytes?. J. Neurosci. 6 (1986) 22-29
30. Pike C.J. Estrogen modulates neuronal Bcl-XL expression and betaamyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72 (1999) 1552-1563
31. Platania P., Seminara G., Aronica E., Troost D., Catania M.V., and Sortino M.A. 17β-estradiol rescues spinal motoneurons from AMPA-induced toxicity: A role for glial cells. Neurobiol. Dis. 20 (2005) 461-470
32. Ryan J., Scali J., Carriere I., Ritchie K., and Ancelin M.L. Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int. Psychogeriatr. 20 (2008) 47-56
33. Singer C.A., Rogers K.L., Strickland T.M., and Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212 (1996) 13-16
34. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., and Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19 (1999) 2455-2463
35. Sortino M.A., Chisari M., Merlo S., Vancheri C., Caruso M., Nicoletti F., Canonico P.L., and Copani A. Glia mediates the neuroprotective action of estradiol on (beta)-amyloid-induced neuronal death. Endocrinol. 145 (2004) 5080-5086
36. Suzuki S., Brown C.M., Dela Cruz C.D., Yang E., Bridwell D.A., and Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and anti-inflammatory actions. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6013-6018
37. Toran-Allerand C.D., Guan X., MacLusky N.J., Horvath T.L., Diano S., Singh M., Connolly E.S., Nethrapalli I.S., and Tinnikov A.A. ER-X: a novel plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22 (2002) 8391-8401
38. Vegeto E., Benedusi V., and Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol. 29 (2008) 507-519
39. Vermeiren C., Najimi M., Maloteaux J.M., and Hermans E. Molecular and functional characterisation of glutamate transporters in rat cortical astrocytes exposed to a defined combination of growth factors during in vitro differentiation. Neurochem. Int. 46 (2005) 137-147
40. Vermeiren C., Najimi M., Vanhoutte N., Tilleux S., De Hemptinne I., Maloteaux J.M., and Hermans E. Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes. J. Neurochem. 94 (2005) 405-416
41. Wang X., Simpkins J.W., Dykens J.A., and Cammarata P.R. Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Investig. Ophthalmol. Vis. Sci. 44 (2003) 2067-2075
42. 2 toxicity in human. Mol. Pharmacol. 70 (2006) 395-404
43. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., and Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4 (1998) 447-451
44. Zhao L., O'Neill K., and Brinton R.D. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J. Pharmacol. Exp. Ther. 319 (2006) 1124-1132
45. Zhao L., Wu T., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain. Res. 1010 (2004) 22-34
46. Zhu Y., Yang G.Y., Ahlemeyer B., Pang L., Che X.M., Culmsee C., Klumpp S., and Krieglstein J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci. 22 (2002) 3898-3909